CRC incidence spikes between ages 49 and 50 years

A steep increase in incidence of colorectal cancer among patients aged between 49 and 50 years may suggest that many cases go undetected in younger patients before they reach routine, average-risk screening at age 50 years, according to data published in JAMA Network Open. “Given the current debate over colorectal cancer screening at age 45 vs. 50, we felt it would be revealing to conduct

Immunogenicity And Safety Of The 13-Valent Pneumococcal Conjugate Vacc | CIA

Immunogenicity And Safety Of The 13-Valent Pneumococcal Conjugate Vaccine In Patients With Monoclonal Gammopathy Of Undetermined Significance – Relationship With Selected Immune And Clinical Parameters Marcin Pasiarski,1,2 Barbara Sosnowska-Pasiarska,3 Ewelina Grywalska,4,5 Agnieszka Stelmach-Gołdyś,1 Artur Kowalik,6 Stanisław Góźdź,2,7 Jacek Roliński4,5 1Department of Hematology, Holycross…